Explore the words cloud of the EUPHORIA project. It provides you a very rough idea of what is the project "EUPHORIA" about.
The following table provides information about the project.
ITHERA MEDICAL GMBH
|Coordinator Country||Germany [DE]|
|Total cost||2˙985˙165 €|
|EC max contribution||2˙314˙315 € (78%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-01-01 to 2021-12-31|
Take a look of project's partnership.
|1||ITHERA MEDICAL GMBH||DE (MUNCHEN)||coordinator||887˙541.00|
|2||UNIVERSITATSKLINIKUM ERLANGEN||DE (ERLANGEN)||participant||748˙998.00|
|3||IMASONIC SAS||FR (VORAY SUR L'OGNON)||participant||305˙375.00|
|4||RAYFOS LTD||UK (BASINGSTOKE)||participant||206˙150.00|
|5||PINTAIL LTD||IE (Blackrock)||participant||166˙250.00|
EUPHORIA will pave the way to establish MSOT (Multispectral Optoacoustic Tomography) technology for the non-invasive assessment of intestinal inflammation in patients. EUPHORIA will enable commercialization of the technology by finalizing technical improvements that will increase diagnostic outcome beyond what has been shown in a first feasibility study, will improve usability, prepare CE marking for the new device and validate clinical results in a large clinical study. Inflammatory bowel disease (IBD) is a chronic condition, posing significant burden to patients and health care systems. Patients suffer from a relapsing course of intestinal inflammation, and to date, there is no satisfying non-invasive diagnostic modality for monitoring disease activity. In a recent clinical study conducted by University Hospital Erlangen, MSOT, a technology developed by iThera Medical (ITM), has proven to be superior in diagnostic performance to other procedures. Imasonic (IMA) and RayFos (RFO) are ideally positioned to drive the technical improvement steps: Imasonic, an expert in ultrasound transducer manufacturing, will develop an ultrasound detector with higher signal-to-noise ratio to enable better sensitivity and detection at depth. RayFos specializes on real-time sensing and image inversion, processing and rendering and has significant experience in optoacoustic tomography algorithms and implementation. iThera Medical will lead the incorporation into the device, CE marking and commercialization. The University Hospital Erlangen is an excellence center in IBD and will drive the clinical validation. Pintail has extensive project management, dissemination and commercialization expertise.
|Project website||Websites, patent fillings, videos etc.||2020-01-27 16:12:45|
Take a look to the deliverables list in detail: detailed list of EUPHORIA deliverables.
|year||authors and title||journal||last update|
Adrian P. Regensburger, Lina M. Fonteyne, JÃ¶rg JÃ¼ngert, Alexandra L. Wagner, Teresa Gerhalter, Armin M. Nagel, Rafael Heiss, Florian Flenkenthaler, Matthias Qurashi, Markus F. Neurath, Nikolai Klymiuk, Elisabeth Kemter, Thomas FrÃ¶hlich, Michael Uder, Joachim Woelfle, Wolfgang Rascher, Regina Trollmann, Eckhard Wolf, Maximilian J. Waldner, Ferdinand Knieling
Detection of collagens by multispectral optoacoustic tomography as an imaging biomarker for Duchenne muscular dystrophy
published pages: 1905-1915, ISSN: 1078-8956, DOI: 10.1038/s41591-019-0669-y
|Nature Medicine 25/12||2020-01-28|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EUPHORIA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EUPHORIA" are provided by the European Opendata Portal: CORDIS opendata.